| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/24/2009 | WO2009116695A1 A composition for treatment and improvement of diabetes comprising caveolin as active ingredient and a method for treatment of diabetes using it |
| 09/24/2009 | WO2009116636A1 Mineral-enriched soybean protein solution |
| 09/24/2009 | WO2009116529A1 Polypeptide and pharmaceutical composition containing the polypeptide |
| 09/24/2009 | WO2009116524A1 Modified protein |
| 09/24/2009 | WO2009116509A1 Polymer conjugate of physiologically active substance |
| 09/24/2009 | WO2009116035A1 tPA MUTANT IN THE TREATMENT OF ACUTE BRAIN INJURY AND NEURODEGENERATIVE DISORDERS |
| 09/24/2009 | WO2009115809A2 Thyroid stimulating hormone fusion proteins |
| 09/24/2009 | WO2009115782A2 Compound |
| 09/24/2009 | WO2009115776A1 Cyclopenta[g]quinazoline derivatives for the treatment of rheumatoid arthritis or acute myeloid leukaemia |
| 09/24/2009 | WO2009115664A2 Crystalline structure of the cc2-lz domain of nemo |
| 09/24/2009 | WO2009115658A2 Use of a caspase-1 inhibitor for treating atherosclerotic plaque |
| 09/24/2009 | WO2009115634A1 Synergic 5'-methylthioadenosine combinations |
| 09/24/2009 | WO2009115568A1 Anti-lps factor from parietaria judaica and methods of use thereof |
| 09/24/2009 | WO2009115548A2 Method for the treatment of ischemia reperfusion injury |
| 09/24/2009 | WO2009115525A2 Preparation of a pharmaceutical composition for increasing bone mineral density |
| 09/24/2009 | WO2009115469A1 Protease stabilized, acylated insulin analogues |
| 09/24/2009 | WO2009115287A1 Thiostrepton derivatives |
| 09/24/2009 | WO2009115007A1 Use of tat-n25 polypeptide in treating dermatosis relative to abnormal growth of cell and psoriasis |
| 09/24/2009 | WO2009114943A1 Peptide composition for cancer treatment by inhibiting trpv6 calcium channel activity |
| 09/24/2009 | WO2009095261A3 Vaccine compositions |
| 09/24/2009 | WO2009094742A9 Toxin of the spider phoneutria nigriventer for treatment of erectile dysfunction |
| 09/24/2009 | WO2009089062A3 Cadherin-11 ecl domain antagonists for treating inflammatory joint disorders |
| 09/24/2009 | WO2009089059A3 Therapeutic inhibitors of pai-1 function and methods of their use |
| 09/24/2009 | WO2009085269A3 Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions |
| 09/24/2009 | WO2009081152A3 Antimicrobial compounds |
| 09/24/2009 | WO2009068688A3 Composition for treatment and prevention of hair loss and premature graying of hair |
| 09/24/2009 | WO2009063333A3 Compositions and methods to increase bioavailability of carotenoids |
| 09/24/2009 | WO2009062750A3 Active soluble post-translationally modified neuregulin isoforms |
| 09/24/2009 | WO2009062102A3 Compositions and methods for treatment of microbial disorders |
| 09/24/2009 | WO2009061807A3 Activin receptor-like kinase-i antagonist compositions and methods of use |
| 09/24/2009 | WO2009059755A3 Novel neurturin conjugates for pharmaceutical use |
| 09/24/2009 | WO2009059298A3 Compositions and methods of enhancinc immune responses to eimeria |
| 09/24/2009 | WO2009058690A3 Nell-1 compositions |
| 09/24/2009 | WO2009044406A3 Stearically stabilized unilamilar vesicles, process for preparation thereof and use thereof |
| 09/24/2009 | WO2009044279A3 Peptides having antimicrobial and/or biosurfactant properties |
| 09/24/2009 | WO2009044273A3 Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response |
| 09/24/2009 | WO2009040726A3 Rhamnose antagonists and use thereof |
| 09/24/2009 | WO2009040068A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040067A3 Use of a peptide as a therapeutic agent |
| 09/24/2009 | WO2009040049A3 Use of acetyl- (ala10, 11)-rantes (1-14) and/or calcitonin as anti-angiogenic agents |
| 09/24/2009 | WO2009037566A9 Hyaluronidase and method of use thereof |
| 09/24/2009 | WO2009037061A3 Use of hydrophobin polypeptides as penetration enhancers |
| 09/24/2009 | WO2009035540A3 Analogues of exendin-4 and exendin-3 |
| 09/24/2009 | WO2009033681A3 Cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2009033680A3 Galanin-like peptide alone or in combination with cyclo-argd as a therapeutic agent |
| 09/24/2009 | WO2008106657A3 Encapsulated amyloid-beta peptides |
| 09/24/2009 | WO2008091698A3 Liquid mixing and injecting tool |
| 09/24/2009 | WO2008057608A3 Synthetic peptide amides |
| 09/24/2009 | WO2004045516A9 Compositions and methods for the diagnosis and treatment of tumor |
| 09/24/2009 | WO2002079384A9 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 09/24/2009 | US20090241205 Collapsin Response Mediator Protein, CRMP; lacosamide a new analgesic and antiepileptic agent, interacts with CRMP; drug screening, pharmacogenetics |
| 09/24/2009 | US20090240039 Polypeptide fusion |
| 09/24/2009 | US20090240031 Process and intermediate products for preparing cardiodilatin fragments, and highly purified cardiodilatin fragments |
| 09/24/2009 | US20090240027 Intermediates for macrocyclic compounds |
| 09/24/2009 | US20090239938 Preventive/remedy for arteriosclerosis |
| 09/24/2009 | US20090239811 Polycationic compounds and uses thereof |
| 09/24/2009 | US20090239810 NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE |
| 09/24/2009 | US20090239809 Process For Preparing Peptide Products For Promoting Cholecystokinin Secretion And Use Of The Peptide Products |
| 09/24/2009 | US20090239808 Calcium receptor activator |
| 09/24/2009 | US20090239807 Methods and kits for diagnosing and/or assessing severity and treating gaucher disease |
| 09/24/2009 | US20090239806 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same |
| 09/24/2009 | US20090239805 Human 3 relaxin |
| 09/24/2009 | US20090239804 Prevention and treatment of osteoarthritis |
| 09/24/2009 | US20090239803 Bite-size carbohydrate nutritional products and methods for using same |
| 09/24/2009 | US20090239802 Hsp70 PEPTIDE STIMULATING NATURAL KILLER (NK) CELL ACTIVITY AND USES THEREOF |
| 09/24/2009 | US20090239801 Modified Fusion Polypeptides |
| 09/24/2009 | US20090239800 CLC Channel Ligand |
| 09/24/2009 | US20090239799 Pharmaceutical Compositions Comprising Ccl2 and Use of Same For The Treatment of Inflammation |
| 09/24/2009 | US20090239798 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 09/24/2009 | US20090239797 Production of high levels of transgenic factor ix without gene rescue, and its therapeutic uses |
| 09/24/2009 | US20090239796 Methods for treating diabetes and reducing body weight |
| 09/24/2009 | US20090239795 exendin-4 fused to a transferrin (Tf) via a polypeptide linker; for treatment of Type II diabetes, obesity, and to reduce body weight |
| 09/24/2009 | US20090239794 Hcv f protein and uses thereof |
| 09/24/2009 | US20090239793 Polynucleotides and polypeptides associated with trophoblast cell death, differentiation, invasion, and/or cell fusion and turnover |
| 09/24/2009 | US20090239792 Short fatty acid tail polymyxin derivatives and uses thereof |
| 09/24/2009 | US20090239791 Pharmaceutical composition containing lipophilic substance which inhibits il-2 production |
| 09/24/2009 | US20090239790 Novel recombinant proteins with n-terminal free thiol |
| 09/24/2009 | US20090239789 Methods of treatment with drug loaded polymeric materials |
| 09/24/2009 | US20090239788 Recombinant or transgenic factor vii compound having a majority of glycan, biantennary, bisialylated and non-fucosylated forms |
| 09/24/2009 | US20090239787 Self-foaming cement for void filling and/or delivery systems |
| 09/24/2009 | US20090239786 Novel Biomaterial Drug Delivery and Surface Modification Compositions |
| 09/24/2009 | US20090239785 Insulin Derivative |
| 09/24/2009 | US20090239784 Stablised Insulin Compositions |
| 09/24/2009 | US20090239783 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 09/24/2009 | US20090239782 High-molecular weight conjugate of resorcinol derivatives |
| 09/24/2009 | US20090239304 Bioactive peptide for cell adhesion |
| 09/24/2009 | US20090239264 Vaccine delivery; attaching immunogenic determinant of heterologous polypeptide biodrug to the peptidoglycan microparticle on cell wall of a Gram-positive bacterium; improve the binding by treating the cell wall with acid solution to remove protein, lipotechoic, carbohydrates |
| 09/24/2009 | US20090239240 Mutant Forms of Fas Ligand and Uses Thereof |
| 09/24/2009 | US20090239236 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy |
| 09/24/2009 | US20090239219 Telomerase expression repressor proteins and methods of using the same |
| 09/24/2009 | US20090238896 Compositions and methods for diagnosing and treating melanoma |
| 09/24/2009 | US20090238895 Nutritional and/or pharmaceutical preparation for use in prophylaxis and treatment of disturbances in microelements absorption from the alimentary canal |
| 09/24/2009 | US20090238892 Deer antler extract for promoting angiogenesis |
| 09/24/2009 | US20090238887 Highly Impact-Resistant Granules |
| 09/24/2009 | US20090238886 Retro-Inversion Peptides That Target GIT Transport Receptors and Related Methods |
| 09/24/2009 | US20090238883 Liver-specific nanocapsules and methods of using |
| 09/24/2009 | US20090238882 Carbon-substituted diketopiperazine delivery systems |
| 09/24/2009 | US20090238879 Delivery scaffolds and related methods of use |
| 09/24/2009 | US20090238876 Bisphosphonates for treating endometriosis |
| 09/24/2009 | US20090238874 Biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan |